101 related articles for article (PubMed ID: 15973992)
41. The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: a quantitative reverse transcriptase-polymerase chain reaction analysis.
Elsamman EM; Fukumori T; Tanimoto S; Nakanishi R; Takahashi M; Toida K; Kanayama HO
BJU Int; 2006 Sep; 98(3):668-73. PubMed ID: 16925770
[TBL] [Abstract][Full Text] [Related]
42. [Establishment of RNA interfering retrovirus vector targeting CXCR4 gene driven by human prostate-specific antigen promoter and its biological effects on prostate cancer cells].
Du YF; Xing YF; Zeng FQ; Lu P; Liu XY; Xiao YJ
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):489-94. PubMed ID: 18069626
[TBL] [Abstract][Full Text] [Related]
43. Characterization of prostate-specific antigen binding peptides selected by phage display technology.
Ferrieu-Weisbuch C; Michel S; Collomb-Clerc E; Pothion C; Deléage G; Jolivet-Reynaud C
J Mol Recognit; 2006; 19(1):10-20. PubMed ID: 16312021
[TBL] [Abstract][Full Text] [Related]
44. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
[TBL] [Abstract][Full Text] [Related]
45. Alternative pathways to prostate carcinoma activate prostate stem cell antigen expression.
Dubey P; Wu H; Reiter RE; Witte ON
Cancer Res; 2001 Apr; 61(8):3256-61. PubMed ID: 11309275
[TBL] [Abstract][Full Text] [Related]
46. Selection of human anti-HAV McAb from a phage antibody library.
Wan Z; Wang H; Jiang S
Chin J Biotechnol; 1998; 14(3):173-8. PubMed ID: 10503077
[TBL] [Abstract][Full Text] [Related]
47. Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA+ prostate tumor cells.
Arndt C; Feldmann A; Töpfer K; Koristka S; Cartellieri M; Temme A; Ehninger A; Ehninger G; Bachmann M
Prostate; 2014 Sep; 74(13):1347-58. PubMed ID: 25053504
[TBL] [Abstract][Full Text] [Related]
48. Role of prostate stem cell antigen in prostate cancer research.
Jalkut MW; Reiter RE
Curr Opin Urol; 2002 Sep; 12(5):401-6. PubMed ID: 12172427
[TBL] [Abstract][Full Text] [Related]
49. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.
Reiter RE; Gu Z; Watabe T; Thomas G; Szigeti K; Davis E; Wahl M; Nisitani S; Yamashiro J; Le Beau MM; Loda M; Witte ON
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1735-40. PubMed ID: 9465086
[TBL] [Abstract][Full Text] [Related]
50. [Expression of prostate stem cell antigen and Claudin-4 in human pancreatic carcinoma].
Yagn WB; Cai F; Cheng CT; Cao G; Qin ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Dec; 30(6):728-31. PubMed ID: 19180924
[TBL] [Abstract][Full Text] [Related]
51. Retargeting of T cells to prostate stem cell antigen expressing tumor cells: comparison of different antibody formats.
Feldmann A; Stamova S; Bippes CC; Bartsch H; Wehner R; Schmitz M; Temme A; Cartellieri M; Bachmann M
Prostate; 2011 Jun; 71(9):998-1011. PubMed ID: 21541976
[TBL] [Abstract][Full Text] [Related]
52. Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer.
Gu Z; Thomas G; Yamashiro J; Shintaku IP; Dorey F; Raitano A; Witte ON; Said JW; Loda M; Reiter RE
Oncogene; 2000 Mar; 19(10):1288-96. PubMed ID: 10713670
[TBL] [Abstract][Full Text] [Related]
53. Prostate stem cell antigen and cancer risk, mechanisms and therapeutic implications.
Yang X; Guo Z; Liu Y; Si T; Yu H; Li B; Tian W
Expert Rev Anticancer Ther; 2014 Jan; 14(1):31-7. PubMed ID: 24308679
[TBL] [Abstract][Full Text] [Related]
54. Prostate stem cell antigen: a prospective therapeutic and diagnostic target.
Raff AB; Gray A; Kast WM
Cancer Lett; 2009 May; 277(2):126-32. PubMed ID: 18838214
[TBL] [Abstract][Full Text] [Related]
55. MRl of prostate cancer antigen expression for diagnosis and immunotherapy.
Ren J; Wang F; Wei G; Yang Y; Liu Y; Wei M; Huan Y; Larson AC; Zhang Z
PLoS One; 2012; 7(6):e38350. PubMed ID: 22761679
[TBL] [Abstract][Full Text] [Related]
56. Anti-prostate stem cell antigen monoclonal antibody 1G8 induces cell death in vitro and inhibits tumor growth in vivo via a Fc-independent mechanism.
Gu Z; Yamashiro J; Kono E; Reiter RE
Cancer Res; 2005 Oct; 65(20):9495-500. PubMed ID: 16230414
[TBL] [Abstract][Full Text] [Related]
57. Selection of single chain antibody fragments binding to the extracellular domain of 4-1BB receptor by phage display technology.
Bagheri S; Yousefi M; Safaie Qamsari E; Riazi-Rad F; Abolhassani M; Younesi V; Dorostkar R; Movassaghpour AA; Sharifzadeh Z
Tumour Biol; 2017 Mar; 39(3):1010428317695924. PubMed ID: 28347235
[TBL] [Abstract][Full Text] [Related]
58. Engineered humanized diabodies for microPET imaging of prostate stem cell antigen-expressing tumors.
Leyton JV; Olafsen T; Sherman MA; Bauer KB; Aghajanian P; Reiter RE; Wu AM
Protein Eng Des Sel; 2009 Mar; 22(3):209-16. PubMed ID: 18957406
[TBL] [Abstract][Full Text] [Related]
59. Selective expression of murine prostate stem cell antigen in fetal and adult tissues and the transgenic adenocarcinoma of the mouse prostate model of prostate carcinogenesis.
Ross S; Spencer SD; Lasky LA; Koeppen H
Am J Pathol; 2001 Mar; 158(3):809-16. PubMed ID: 11238029
[TBL] [Abstract][Full Text] [Related]
60. Growth delay of human bladder cancer cells by Prostate Stem Cell Antigen downregulation is associated with activation of immune signaling pathways.
Marra E; Uva P; Viti V; Simonelli V; Dogliotti E; De Rinaldis E; Lahm A; La Monica N; Nicosia A; Ciliberto G; Palombo F
BMC Cancer; 2010 Apr; 10():129. PubMed ID: 20374648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]